Giancarlo Scoppettuolo Selected Research

Giancarlo Scoppettuolo Research Topics

Disease

20	Infections 01/2023 - 08/2006
10	Sepsis (Septicemia) 05/2023 - 02/2012
6	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 02/2013
4	Thrombosis (Thrombus) 07/2022 - 02/2013
2	COVID-19 05/2023 - 01/2021
2	Neoplasms (Cancer) 01/2023 - 01/2005
2	Critical Illness (Critically Ill) 05/2022 - 03/2018
2	Hemorrhage 04/2022 - 07/2021
2	Communicable Diseases (Infectious Diseases) 01/2019 - 01/2015
2	Fungemia 10/2014 - 08/2006
2	Lymphoma (Lymphomas) 01/2012 - 01/2005
1	Catheter-Related Infections 01/2023
1	Thrombophlebitis 05/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Hydrocephalus (Hydrocephaly) 01/2022
1	Fever (Fevers) 01/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 03/2019
1	Skin Abnormalities 01/2019
1	Candidemia 01/2019
1	Wounds and Injuries (Trauma) 10/2018
1	Meningitis 08/2017
1	Central Nervous System Infections (Central Nervous System Infection) 08/2017
1	Endocarditis 03/2017
1	Surgical Wound Infection 02/2017
1	Flushing 11/2016
1	Bacteremia 01/2015
1	Spondylosis 12/2014
1	Lyme Disease (Disease, Lyme) 12/2014
1	Rupture 11/2014
1	Carcinoma (Carcinomatosis) 10/2014
1	Fever of Unknown Origin 02/2013
1	Hematoma 02/2013
1	Brain Abscess (Abscess, Brain) 01/2013
1	Neutropenia 01/2012
1	Febrile Neutropenia 01/2012
1	Atrial Fibrillation 10/2011
1	Extravasation of Diagnostic and Therapeutic Materials 10/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2005
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2005
1	Opportunistic Infections (Opportunistic Infection) 01/2005

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2013
2	taurolidineIBA 01/2023 - 11/2016
2	Vancomycin FDA LinkGeneric 05/2022 - 11/2016
2	ChlorhexidineIBA 07/2021 - 02/2017
1	C-Reactive ProteinIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 07/2021
1	Tigecycline (Tygacil)FDA Link 08/2017
1	6-methylprednisolone-21-hemisuberate N,N,N'-triethylenediamine amideIBA 04/2017
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2017
1	carbapenemaseIBA 04/2017
1	IceIBA 03/2017
1	IodineIBA 02/2017
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2016
1	ethyleneIBA 11/2016
1	Linezolid (Zyvox)FDA Link 11/2016
1	Saline SolutionIBA 11/2016
1	Ethanol (Ethyl Alcohol)IBA 11/2016
1	DiaminesIBA 11/2016
1	Edetic Acid (EDTA)FDA Link 11/2016
1	Heparin (Liquaemin)FDA LinkGeneric 11/2016
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2016
1	SolutionsIBA 11/2016
1	Acetic Acid (Vinegar)FDA LinkGeneric 11/2016
1	Citric Acid (Citrate)FDA LinkGeneric 11/2016
1	16S Ribosomal RNAIBA 01/2015
1	A 19IBA 11/2014
1	Filgrastim (Neupogen)FDA Link 01/2012
1	pegfilgrastim (Neulasta)FDA Link 01/2012
1	Fluconazole (Zonal)FDA LinkGeneric 08/2006
1	AzolesIBA 08/2006
1	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2006
1	DNA (Deoxyribonucleic Acid)IBA 01/2005

Therapy/Procedure

19	Catheters 05/2023 - 10/2011
11	Therapeutics 01/2023 - 01/2005
4	Central Venous Catheters 03/2019 - 02/2012
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2005
2	Punctures 04/2014 - 02/2013
1	Intravenous Infusions 05/2022
1	Cannula 05/2022
1	Cerebrospinal Fluid Shunts 01/2022
1	Noninvasive Ventilation 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Decompressive Craniectomy 10/2018
1	Lasers (Laser) 01/2015
1	Injections 11/2014
1	Infusion Pumps (Infusion Pump) 11/2014
1	Neurosurgical Procedures 01/2013
1	Subcutaneous Injections 01/2012
1	Contraindications 10/2011
1	Highly Active Antiretroviral Therapy (HAART) 01/2005